Home
About Us
Products & Solutions
Cardiovascular
Laboratory Solutions
Investor
Company Profile
Fact Sheet
Awards & Recognitions
Organisation Structure
Results / Financial Information
Quarterly Results
Annual Reports
Annual Returns
Financials of Subsidiary Companies
Financial Details of Group Companies
Shareholders’ Communication
Scheme of Amalgamation
Notice to Shareholders
Corporate Governance
Board of Directors
Board Committees
Memorandum of Association & Articles of Association
Company Policies
CSR
Officials Responsible for Determination and Disclosure of Material Events
Terms & Conditions of Appointment of Independent Directors
Secretarial Compliance Report
Shares
Share Price
Shareholding Pattern
ESOPs
Investor Support
Contact Details
Downloads
FAQs
Stock Exchange Submission
Presentations / Analyst or Institutional Investors Meeting
Disclosures under Regulation 46 of the SEBI (LODR) Regulations, 2015
IPO / Offer Documents
Draft Red Herring Prospectus
Addendum to the DRHP
Audio-Visual Red Herring Prospectus
Details of Outstanding Dues to Material Creditors
Industry Report
News & Updates
Careers
Contact
Navigation
Company Profile
Fact Sheet
Awards & Recognitions
Organisation Structure
Results / Financial Information
Quarterly Results
Annual Reports
Annual Returns
Financials of Subsidiary Companies
Financial Details of Group Companies
Shareholders’ Communication
Scheme of Amalgamation
Notice to Shareholders
Corporate Governance
Board of Directors
Board Committees
Memorandum of Association & Articles of Association
Company Policies
CSR
Officials Responsible for Determination and Disclosure of Material Events
Terms & Conditions of Appointment of Independent Directors
Secretarial Compliance Report
Shares
Share Price
Shareholding Pattern
ESOPs
Investor Support
Contact Details
Downloads
FAQs
Stock Exchange Submission
Presentations / Analyst or Institutional Investors Meeting
Disclosures under Regulation 46 of the SEBI (LODR) Regulations, 2015
IPO / Offer Documents
Draft Red Herring Prospectus
Addendum to the DRHP
Audio-Visual Red Herring Prospectus
Details of Outstanding Dues to Material Creditors
Industry Report
Home
/
Investor Relations
/
Results / Financial Information
/
Financials of Subsidiary Companies
Financials of Subsidiary Companies
Everlife
16 documents
Analisa Resources (M) Sdn Bhd Financials FY 25-26
Biofrontier Technologies Pte Ltd Financials FY 25-26
Chemopharm Sdn Bhd Financials FY 25-26
Chemoscience Pte. Ltd. Financials FY 25-26
CPC Diagnostics Pvt Ltd INDAS Financials FY 25-26
Everlife Holdings Pte. Ltd. Financials FY 25-26
Everlife Philippines Holding Inc Financials FY 25-26
Hausen Bernstein Co. Ltd. Financials FY 25-26
Lifeline Diagnostics Supplies Inc Financials FY 25-26
Lifeline Holding Inc Financials FY 25-26
Medigene Sdn Bhd Financials FY 25-26
Neoscience Sdn Bhd Financials FY 25-26
Research Instruments Pte Ltd Financials FY 25-26
Research Instruments Sdn Bhd Financials FY 25-26
Research Instruments Vietnam Co Ltd Financials FY 25-26
Scientific Resources Pte Ltd Financials FY 25-26
LAMED Vertriebsgesellschaft mbH
1 document
LAMED Vertriebsgesellschaft mbH FS INR 2025-24
Transhealth
3 documents
Transhealth (THPL) FS March 2025
Transhealth (THPL) FS March 2024
Transhealth (THPL) FS March 2023
Translumina GmbH
2 documents
Translumina GmbH FS INR 2025-24
Translumina GmbH FS INR 2024-23
Translumina Therapeutics
3 documents
Translumina Therapeutics (TTLP) FS March 2025
Translumina Therapeutics (TTLP) FS March 2024
Translumina Therapeutics (TTLP) FS March 2023